The rise of Viagra initially drove a boom for major pharmaceutical companies, nevertheless recent developments present a complicated outlook for shareholders. Lower-cost versions are reducing earnings, and ongoing https://macieppes536322.mdkblog.com/47328759/the-blue-pill-and-big-pharma-a-precarious-investment